Chargement en cours...
Isradipine Versus Placebo in Early Parkinson Disease A Randomized Trial
BACKGROUND: Studies suggest that dihydropyridine calcium-channel blockers may be associated with reduced risk for Parkinson disease (PD). OBJECTIVE: To assess the effect of isradipine, a dihydropyridine calcium-channel blocker, on the rate of clinical progression of PD. DESIGN: Multicenter, randomiz...
Enregistré dans:
| Publié dans: | Ann Intern Med |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7465126/ https://ncbi.nlm.nih.gov/pubmed/32227247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-2534 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|